| Entry |
|
|---|
| Name |
Licaminlimab (USAN/INN) |
|---|
| Formula |
C1175H1788N322O374S10
|
|---|
| Exact mass |
26712.7998
|
|---|
| Mol weight |
26729.37
|
|---|
| Sequence |
MEIVMTQSPS TLSASVGDRV IITCQSSQSV YGNIWMAWYQ QKPGRAPKLL IYQASKLASG
VPSRFSGSGS GAEFTLTISS LQPDDFATYY CQGNFNTGDR YAFGQGTKLT VLGGGGGSGG
GGSGGGGSGG GGSEVQLVES GGGSVQPGGS LRLSCTASGF TISRSYWICW VRQAPGKGLE
WVGCIYGDND ITPLYANWAK GRFTISRDTS KNTVYLQMNS LRAEDTATYY CARLGYADYA
YDLWGQGTTV TVSS
(Disulfide bridge: 24-91, 155-231, 169-184) |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Anti-inflammatory, Immunomodulator, Anti-TNF-alpha antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of uveitis and dry eye
|
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokines
Tumor necrosis factors
TNF (TNFA, TNFSF2)
D12420 Licaminlimab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
